MicroVention’s Stents Win FDA Pre-Market Approval

The FDA granted pre-market approval for MicroVention’s neurovascular stents used to treat aneurysms.

Previously approved under a humanitarian device exemption, the stents feature low-profiles and consistent visibility for use in patients suffering from wide-neck aneurysms.

The devices are used to stabilize the blood vessels around the opening to a wide-neck aneurysm while a coil is deployed within the aneurysm.